カテゴリー： 世界, 医療/バイオ, LP Information

世界の不眠症用オレキシン受容体拮抗薬市場予測 2023年-2029年

【英語タイトル】Global Orexin Receptor Antagonists for Insomnia Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08910）・商品コード：LP23DC08910
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：71
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の不眠症用オレキシン受容体拮抗薬市場」は、過去の販売実績から2022年の世界の不眠症用オレキシン受容体拮抗薬の総販売量を検討し、2023年から2029年の予測される不眠症用オレキシン受容体拮抗薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の不眠症用オレキシン受容体拮抗薬の市場規模を掲載し、XXX百万米ドル規模の世界の不眠症用オレキシン受容体拮抗薬市場の詳細な分析を提供します。本インサイトレポートは、世界の不眠症用オレキシン受容体拮抗薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の不眠症用オレキシン受容体拮抗薬市場における各社の独自のポジションをより深く理解するために、不眠症用オレキシン受容体拮抗薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の不眠症用オレキシン受容体拮抗薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。不眠症用オレキシン受容体拮抗薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。不眠症用オレキシン受容体拮抗薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。不眠症用オレキシン受容体拮抗薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

不眠症用オレキシン受容体拮抗薬の世界主要メーカーとしては、MSD、 Eisai Co., Ltd.、 Idorsiaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の不眠症用オレキシン受容体拮抗薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では不眠症用オレキシン受容体拮抗薬市場をセグメンテーションし、種類別 (OX1R、OX2R)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：OX1R、OX2R

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の不眠症用オレキシン受容体拮抗薬市場の10年間の市場状況・展望は？
・世界および地域別に見た不眠症用オレキシン受容体拮抗薬市場成長の要因は何か？
・不眠症用オレキシン受容体拮抗薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・不眠症用オレキシン受容体拮抗薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：不眠症用オレキシン受容体拮抗薬の年間販売量2018-2029、地域別現状・将来分析
・不眠症用オレキシン受容体拮抗薬の種類別セグメント：OX1R、OX2R
・不眠症用オレキシン受容体拮抗薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・不眠症用オレキシン受容体拮抗薬の用途別セグメント：病院、診療所、その他
・不眠症用オレキシン受容体拮抗薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の不眠症用オレキシン受容体拮抗薬市場
・企業別のグローバル不眠症用オレキシン受容体拮抗薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の不眠症用オレキシン受容体拮抗薬の年間売上：2018-2023年の売上、市場シェア
・企業別の不眠症用オレキシン受容体拮抗薬販売価格
・主要企業の不眠症用オレキシン受容体拮抗薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

不眠症用オレキシン受容体拮抗薬の地域別レビュー
・地域別の不眠症用オレキシン受容体拮抗薬市場規模2018-2023：年間販売量、売上
・主要国別の不眠症用オレキシン受容体拮抗薬市場規模2018-2023：年間販売量、売上
・南北アメリカの不眠症用オレキシン受容体拮抗薬販売の成長
・アジア太平洋の不眠症用オレキシン受容体拮抗薬販売の成長
・ヨーロッパの不眠症用オレキシン受容体拮抗薬販売の成長
・中東・アフリカの不眠症用オレキシン受容体拮抗薬販売の成長

南北アメリカ市場
・南北アメリカの国別の不眠症用オレキシン受容体拮抗薬販売量、売上（2018-2023）
・南北アメリカの不眠症用オレキシン受容体拮抗薬の種類別販売量
・南北アメリカの不眠症用オレキシン受容体拮抗薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の不眠症用オレキシン受容体拮抗薬販売量、売上（2018-2023）
・アジア太平洋の不眠症用オレキシン受容体拮抗薬の種類別販売量
・アジア太平洋の不眠症用オレキシン受容体拮抗薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の不眠症用オレキシン受容体拮抗薬販売量、売上（2018-2023）
・ヨーロッパの不眠症用オレキシン受容体拮抗薬の種類別販売量
・ヨーロッパの不眠症用オレキシン受容体拮抗薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の不眠症用オレキシン受容体拮抗薬販売量、売上（2018-2023）
・中東・アフリカの不眠症用オレキシン受容体拮抗薬の種類別販売量
・中東・アフリカの不眠症用オレキシン受容体拮抗薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・不眠症用オレキシン受容体拮抗薬の製造コスト構造分析
・不眠症用オレキシン受容体拮抗薬の製造プロセス分析
・不眠症用オレキシン受容体拮抗薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・不眠症用オレキシン受容体拮抗薬の主要なグローバル販売業者
・不眠症用オレキシン受容体拮抗薬の主要なグローバル顧客

地域別の不眠症用オレキシン受容体拮抗薬市場予測レビュー
・地域別の不眠症用オレキシン受容体拮抗薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・不眠症用オレキシン受容体拮抗薬の種類別市場規模予測
・不眠症用オレキシン受容体拮抗薬の用途別市場規模予測

主要企業分析
MSD、 Eisai Co., Ltd.、 Idorsia
・企業情報
・不眠症用オレキシン受容体拮抗薬製品
・不眠症用オレキシン受容体拮抗薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Orexin Receptor Antagonists for Insomnia market size is projected to grow from US$ 1076.1 million in 2022 to US$ 3354.3 million in 2029; it is expected to grow at a CAGR of 17.6% from 2023 to 2029.
United States market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orexin Receptor Antagonists for Insomnia players cover MSD, Eisai Co., Ltd. and Idorsia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Suvoresan is believed to play a therapeutic role in the treatment of insomnia by blocking orexin receptors and inhibiting the effects of endogenous wake-promoting orexin neuropeptides OX-A and OX-B.
LPI (LP Information)’ newest research report, the “Orexin Receptor Antagonists for Insomnia Industry Forecast” looks at past sales and reviews total world Orexin Receptor Antagonists for Insomnia sales in 2022, providing a comprehensive analysis by region and market sector of projected Orexin Receptor Antagonists for Insomnia sales for 2023 through 2029. With Orexin Receptor Antagonists for Insomnia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orexin Receptor Antagonists for Insomnia industry.
This Insight Report provides a comprehensive analysis of the global Orexin Receptor Antagonists for Insomnia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orexin Receptor Antagonists for Insomnia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orexin Receptor Antagonists for Insomnia market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orexin Receptor Antagonists for Insomnia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orexin Receptor Antagonists for Insomnia.
This report presents a comprehensive overview, market shares, and growth opportunities of Orexin Receptor Antagonists for Insomnia market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
OX1R
OX2R
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
MSD
Eisai Co., Ltd.
Idorsia
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orexin Receptor Antagonists for Insomnia market?
What factors are driving Orexin Receptor Antagonists for Insomnia market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orexin Receptor Antagonists for Insomnia market opportunities vary by end market size?
How does Orexin Receptor Antagonists for Insomnia break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Orexin Receptor Antagonists for Insomnia by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Orexin Receptor Antagonists for Insomnia by Country/Region, 2018, 2022 & 2029
2.2 Orexin Receptor Antagonists for Insomnia Segment by Type
2.2.1 OX1R
2.2.2 OX2R
2.3 Orexin Receptor Antagonists for Insomnia Sales by Type
2.3.1 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
2.3.2 Global Orexin Receptor Antagonists for Insomnia Revenue and Market Share by Type (2018-2023)
2.3.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Type (2018-2023)
2.4 Orexin Receptor Antagonists for Insomnia Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Orexin Receptor Antagonists for Insomnia Sales by Application
2.5.1 Global Orexin Receptor Antagonists for Insomnia Sale Market Share by Application (2018-2023)
2.5.2 Global Orexin Receptor Antagonists for Insomnia Revenue and Market Share by Application (2018-2023)
2.5.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Application (2018-2023)
3 Global Orexin Receptor Antagonists for Insomnia by Company
3.1 Global Orexin Receptor Antagonists for Insomnia Breakdown Data by Company
3.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Company (2018-2023)
3.1.2 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company (2018-2023)
3.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Company (2018-2023)
3.2.1 Global Orexin Receptor Antagonists for Insomnia Revenue by Company (2018-2023)
3.2.2 Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company (2018-2023)
3.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Company
3.4 Key Manufacturers Orexin Receptor Antagonists for Insomnia Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orexin Receptor Antagonists for Insomnia Product Location Distribution
3.4.2 Players Orexin Receptor Antagonists for Insomnia Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Orexin Receptor Antagonists for Insomnia by Geographic Region
4.1 World Historic Orexin Receptor Antagonists for Insomnia Market Size by Geographic Region (2018-2023)
4.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Orexin Receptor Antagonists for Insomnia Market Size by Country/Region (2018-2023)
4.2.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Country/Region (2018-2023)
4.2.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Country/Region (2018-2023)
4.3 Americas Orexin Receptor Antagonists for Insomnia Sales Growth
4.4 APAC Orexin Receptor Antagonists for Insomnia Sales Growth
4.5 Europe Orexin Receptor Antagonists for Insomnia Sales Growth
4.6 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Growth
5 Americas
5.1 Americas Orexin Receptor Antagonists for Insomnia Sales by Country
5.1.1 Americas Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
5.1.2 Americas Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
5.2 Americas Orexin Receptor Antagonists for Insomnia Sales by Type
5.3 Americas Orexin Receptor Antagonists for Insomnia Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orexin Receptor Antagonists for Insomnia Sales by Region
6.1.1 APAC Orexin Receptor Antagonists for Insomnia Sales by Region (2018-2023)
6.1.2 APAC Orexin Receptor Antagonists for Insomnia Revenue by Region (2018-2023)
6.2 APAC Orexin Receptor Antagonists for Insomnia Sales by Type
6.3 APAC Orexin Receptor Antagonists for Insomnia Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Orexin Receptor Antagonists for Insomnia by Country
7.1.1 Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
7.1.2 Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
7.2 Europe Orexin Receptor Antagonists for Insomnia Sales by Type
7.3 Europe Orexin Receptor Antagonists for Insomnia Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Orexin Receptor Antagonists for Insomnia by Country
8.1.1 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
8.1.2 Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
8.2 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Type
8.3 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists for Insomnia
10.3 Manufacturing Process Analysis of Orexin Receptor Antagonists for Insomnia
10.4 Industry Chain Structure of Orexin Receptor Antagonists for Insomnia
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orexin Receptor Antagonists for Insomnia Distributors
11.3 Orexin Receptor Antagonists for Insomnia Customer
12 World Forecast Review for Orexin Receptor Antagonists for Insomnia by Geographic Region
12.1 Global Orexin Receptor Antagonists for Insomnia Market Size Forecast by Region
12.1.1 Global Orexin Receptor Antagonists for Insomnia Forecast by Region (2024-2029)
12.1.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orexin Receptor Antagonists for Insomnia Forecast by Type
12.7 Global Orexin Receptor Antagonists for Insomnia Forecast by Application
13 Key Players Analysis
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.1.3 MSD Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Eisai Co., Ltd.
13.2.1 Eisai Co., Ltd. Company Information
13.2.2 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.2.3 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eisai Co., Ltd. Main Business Overview
13.2.5 Eisai Co., Ltd. Latest Developments
13.3 Idorsia
13.3.1 Idorsia Company Information
13.3.2 Idorsia Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.3.3 Idorsia Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Idorsia Main Business Overview
13.3.5 Idorsia Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Orexin Receptor Antagonists for Insomnia Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Orexin Receptor Antagonists for Insomnia Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of OX1R
Table 4. Major Players of OX2R
Table 5. Global Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 6. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Table 7. Global Orexin Receptor Antagonists for Insomnia Revenue by Type (2018-2023) & ($ million)
Table 8. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2018-2023)
Table 9. Global Orexin Receptor Antagonists for Insomnia Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 11. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Table 12. Global Orexin Receptor Antagonists for Insomnia Revenue by Application (2018-2023)
Table 13. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2018-2023)
Table 14. Global Orexin Receptor Antagonists for Insomnia Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Orexin Receptor Antagonists for Insomnia Sales by Company (2018-2023) & (K Units)
Table 16. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company (2018-2023)
Table 17. Global Orexin Receptor Antagonists for Insomnia Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company (2018-2023)
Table 19. Global Orexin Receptor Antagonists for Insomnia Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Orexin Receptor Antagonists for Insomnia Producing Area Distribution and Sales Area
Table 21. Players Orexin Receptor Antagonists for Insomnia Products Offered
Table 22. Orexin Receptor Antagonists for Insomnia Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Orexin Receptor Antagonists for Insomnia Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Geographic Region (2018-2023)
Table 27. Global Orexin Receptor Antagonists for Insomnia Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Orexin Receptor Antagonists for Insomnia Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Country/Region (2018-2023)
Table 31. Global Orexin Receptor Antagonists for Insomnia Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 34. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 35. Americas Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 37. Americas Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 38. Americas Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 39. APAC Orexin Receptor Antagonists for Insomnia Sales by Region (2018-2023) & (K Units)
Table 40. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Region (2018-2023)
Table 41. APAC Orexin Receptor Antagonists for Insomnia Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region (2018-2023)
Table 43. APAC Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 44. APAC Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 45. Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 46. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 47. Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 49. Europe Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 50. Europe Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Orexin Receptor Antagonists for Insomnia
Table 58. Key Market Challenges & Risks of Orexin Receptor Antagonists for Insomnia
Table 59. Key Industry Trends of Orexin Receptor Antagonists for Insomnia
Table 60. Orexin Receptor Antagonists for Insomnia Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Orexin Receptor Antagonists for Insomnia Distributors List
Table 63. Orexin Receptor Antagonists for Insomnia Customer List
Table 64. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Orexin Receptor Antagonists for Insomnia Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Orexin Receptor Antagonists for Insomnia Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MSD Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 79. MSD Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 80. MSD Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. MSD Main Business
Table 82. MSD Latest Developments
Table 83. Eisai Co., Ltd. Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 84. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 85. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Eisai Co., Ltd. Main Business
Table 87. Eisai Co., Ltd. Latest Developments
Table 88. Idorsia Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 89. Idorsia Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 90. Idorsia Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Idorsia Main Business
Table 92. Idorsia Latest Developments
List of Figures
Figure 1. Picture of Orexin Receptor Antagonists for Insomnia
Figure 2. Orexin Receptor Antagonists for Insomnia Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orexin Receptor Antagonists for Insomnia Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Orexin Receptor Antagonists for Insomnia Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Orexin Receptor Antagonists for Insomnia Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of OX1R
Figure 10. Product Picture of OX2R
Figure 11. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type in 2022
Figure 12. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2018-2023)
Figure 13. Orexin Receptor Antagonists for Insomnia Consumed in Hospital
Figure 14. Global Orexin Receptor Antagonists for Insomnia Market: Hospital (2018-2023) & (K Units)
Figure 15. Orexin Receptor Antagonists for Insomnia Consumed in Clinic
Figure 16. Global Orexin Receptor Antagonists for Insomnia Market: Clinic (2018-2023) & (K Units)
Figure 17. Orexin Receptor Antagonists for Insomnia Consumed in Other
Figure 18. Global Orexin Receptor Antagonists for Insomnia Market: Other (2018-2023) & (K Units)
Figure 19. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2022)
Figure 20. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application in 2022
Figure 21. Orexin Receptor Antagonists for Insomnia Sales Market by Company in 2022 (K Units)
Figure 22. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company in 2022
Figure 23. Orexin Receptor Antagonists for Insomnia Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company in 2022
Figure 25. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 28. Americas Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 29. APAC Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 30. APAC Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 31. Europe Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 32. Europe Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 35. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 36. Americas Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 37. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 38. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 39. United States Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Region in 2022
Figure 44. APAC Orexin Receptor Antagonists for Insomnia Revenue Market Share by Regions in 2022
Figure 45. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 46. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 47. China Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 55. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 56. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 57. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 58. Germany Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 67. Egypt Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists for Insomnia in 2022
Figure 73. Manufacturing Process Analysis of Orexin Receptor Antagonists for Insomnia
Figure 74. Industry Chain Structure of Orexin Receptor Antagonists for Insomnia
Figure 75. Channels of Distribution
Figure 76. Global Orexin Receptor Antagonists for Insomnia Sales Market Forecast by Region (2024-2029)
Figure 77. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の不眠症用オレキシン受容体拮抗薬市場予測 2023年-2029年] (コード：LP23DC08910)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の不眠症用オレキシン受容体拮抗薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のプロスタサイクリン受容体作動薬市場予測 2023年-2029年
  • 世界のメラトニン受容体アゴニスト市場予測 2023年-2029年
  • 世界のベンゾジアゼピン受容体作動薬市場予測 2023年-2029年
  • 世界のGnRH受容体拮抗薬市場2022年：ペプチド、低分子
  • 世界のRAS作用剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆